1. [After care of differentiated thyroid gland carcinoma with special reference to serum thyroglobulin level].
- Author
-
Kanitz W, Böttger IG, Pabst HW, Heidenreich P, and Dirr W
- Subjects
- Carcinoma blood, Combined Modality Therapy, Humans, Iodine Radioisotopes therapeutic use, Radioimmunoassay, Radiotherapy Dosage, Thyroid Hormones therapeutic use, Thyroid Neoplasms blood, Thyroidectomy, Carcinoma therapy, Thyroglobulin blood, Thyroid Neoplasms therapy
- Abstract
The histories of 358 patients with carcinomas of the thyroid have been evaluated. Differentiated carcinomas of the thyroid (84.6%) were treated by means of thyroidectomy, ablative radio-iodine therapy (tissue dose 1000 Gray), TSH-suppressive thyroid hormone medication and, in special cases, external radiation. Even differentiated carcinomas showed a high recurrence rate. Metastases occurred particularly in the lungs, the skeleton and locally; low iodine uptake, particularly in distant metastases from papillary carcinomas, often made it impossible to reach a diagnosis by using radio-iodine. Some pulmonary metastases could only be demonstrated radiologically and some skeletal metastases could be shown radiologically or scintigraphically. A modified follow-up program for differentiated carcinomas is suggested, based on the highly sensitive and specific thyroglobulin determination under TSH suppression (sensitivity 97.9%, specificity 93.6%).
- Published
- 1987
- Full Text
- View/download PDF